A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure

Clinical trial NCT02497937 · COMPLETED

Trial details

NCT number

NCT02497937

Sponsor

GlaxoSmithKline

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2016-04-13

Primary completion

2017-08-21

Enrollment

11

View on ClinicalTrials.gov